Mei Shu-Ting, Li Jie-Jing
Department of Clinical, Guangzhou Oriplamacy Technology Co., Ltd., Guangzhou 510000, Guangdong Province, China.
Department of Research, Guangzhou Oriplamacy Technology Co., Ltd., Guangzhou 510000, Guangdong Province, China.
World J Clin Cases. 2025 Oct 6;13(28):109358. doi: 10.12998/wjcc.v13.i28.109358.
has been used as a traditional herbal therapy for wound management and dermatological conditions worldwide for thousands of years. Scientific evidence has confirmed that acemannan, the bioactive compound in aloe vera gel, exhibits significant anti-inflammatory and immunomodulatory properties that enhance tissue regeneration. This case report describes the successful application of an innovative acemannan-enriched glycolipid sphere dressing derived from aloe vera gel in diabetic foot ulcer (DFU) treatment, which achieved a clinically remarkable outcome.
An 80-year-old female patient with a 20-year history of type 2 diabetes mellitus experienced recurrent diabetic foot pain for 15 years. She had multiple hospitalizations due to acute infections and poorly controlled hyperglycemia. Long-term treatments included metformin and gliclazide. Upon presentation, she had a nonhealing wound on her left dorsal foot, diagnosed as a severe DFU (Texas classification: Grade II, stage D). She declined amputation and opted for conservative treatment. The medical team applied an acemannan-enriched glycolipid sphere dressing five times daily to the left calf and foot, avoiding the wound area. Frequency was reduced to three times daily after scab formation. Weight-bearing on the injured foot was avoided. Through in-person and online consultations, the team managed her lifestyle and diet, emphasizing natural foods. After 5 months, the DFU healed without significant scarring or functional loss. No recurrence was observed during the 2-year follow-up.
Acemannan-enriched glycolipid sphere dressings promote DFU healing. This suggests the potential of these dressings for treating other refractory wounds.
数千年来,芦荟一直作为一种传统草药疗法用于全球范围内的伤口处理和皮肤病治疗。科学证据证实,芦荟凝胶中的生物活性化合物乙酰化甘露聚糖具有显著的抗炎和免疫调节特性,可促进组织再生。本病例报告描述了一种源自芦荟凝胶的创新型富含乙酰化甘露聚糖的糖脂球敷料在糖尿病足溃疡(DFU)治疗中的成功应用,取得了显著的临床效果。
一名80岁女性患者,有20年2型糖尿病病史,反复出现糖尿病足疼痛15年。她因急性感染和血糖控制不佳多次住院。长期治疗包括二甲双胍和格列齐特。就诊时,她左足背有一个不愈合的伤口,诊断为重度DFU(德州分类:II级,D期)。她拒绝截肢,选择保守治疗。医疗团队每天在左小腿和足部应用5次富含乙酰化甘露聚糖的糖脂球敷料,避开伤口区域。结痂形成后频率减至每天3次。避免受伤足部负重。通过面对面和在线咨询,团队管理她的生活方式和饮食,强调天然食物。5个月后,DFU愈合,无明显瘢痕形成或功能丧失。在2年随访期间未观察到复发。
富含乙酰化甘露聚糖的糖脂球敷料可促进DFU愈合。这表明这些敷料在治疗其他难治性伤口方面具有潜力。